Sign up to save your podcasts
Or
Share Oral immunomodulating therapies in relapsing MS
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Oral immunomodulating therapies in relapsing MS
Tobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
View all episodes
By The Lancet Group
5
66 ratings
Tobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
More shows like The Lancet Neurology in conversation with
View all
JAMA Editors' Summary
137 Listeners
NEJM This Week
322 Listeners
Neurology® Podcast
296 Listeners
Health Check
93 Listeners
JNNP Podcast
9 Listeners
Practical Neurology Podcast
49 Listeners
Mayo Clinic Talks
292 Listeners
JAMA Neurology Author Interviews
13 Listeners
Neurology Today in 5
24 Listeners
Neurology Minute
136 Listeners
MDS Podcast
9 Listeners
Neurology Exam Prep Podcast
190 Listeners
The Curious Clinicians
374 Listeners
Continuum Audio
83 Listeners
eanCast: Weekly Neurology
0 Listeners